OTSUKA HLDGS (OS1 BE) stock market data APIs
€50.2931
0(0%)
as of December 19, 2025
Try our APIs with
free plan!
OTSUKA HLDGS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for OS1.BE.
Prev. Close
50.2931
Open
50.2931
High
50.2931
Low
50.2931
52 wk Range
37.6-52.5489
Market Cap
17 330 M
Dividends (Yield)
2.8249
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get OTSUKA HLDGS data using free add-ons & libraries
Get OTSUKA HLDGS Fundamental Data
OTSUKA HLDGS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
OTSUKA HLDGS News
New
Here's Why Momentum in Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTSKY) Should Keep going
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the ...
Otsuka Holdings (TSE:4578): Is the Recent Share Price Rise Backed by Fundamentals?
Otsuka Holdings (TSE:4578) has been on investors’ radar lately, and for good reason. There isn’t a blockbuster announcement making headlines this week, but stock watchers have noticed a steady cli...
Corrections & Amplifications
The name of the GBU-57 bomb, also called the Massive Ordnance Penetrator or MOP, was incorrectly listed as MOPS GBU-57 in a graphic with a World News article on Wednesday about the weapon, which is kn...
Biotech Stock Vera Is Slumping After Monster Gain
Vera Therapeutics stock rocketed nearly 70% on Monday on upbeat data for a kidney-disease trial. Shares are tumbling Friday on a rival’s study. Continue Reading View Comments
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
